TWI388318B - 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液 - Google Patents

具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液 Download PDF

Info

Publication number
TWI388318B
TWI388318B TW095105650A TW95105650A TWI388318B TW I388318 B TWI388318 B TW I388318B TW 095105650 A TW095105650 A TW 095105650A TW 95105650 A TW95105650 A TW 95105650A TW I388318 B TWI388318 B TW I388318B
Authority
TW
Taiwan
Prior art keywords
carnitine
acid
peritoneal dialysis
glucose
solution
Prior art date
Application number
TW095105650A
Other languages
English (en)
Chinese (zh)
Other versions
TW200714279A (en
Inventor
阿多伊尼 阿多伊諾
Original Assignee
西格瑪 陶製藥廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 西格瑪 陶製藥廠 filed Critical 西格瑪 陶製藥廠
Publication of TW200714279A publication Critical patent/TW200714279A/zh
Application granted granted Critical
Publication of TWI388318B publication Critical patent/TWI388318B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW095105650A 2005-03-10 2006-02-20 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液 TWI388318B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10

Publications (2)

Publication Number Publication Date
TW200714279A TW200714279A (en) 2007-04-16
TWI388318B true TWI388318B (zh) 2013-03-11

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095105650A TWI388318B (zh) 2005-03-10 2006-02-20 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液

Country Status (19)

Country Link
US (1) US20080138443A1 (OSRAM)
EP (1) EP1858504B1 (OSRAM)
JP (2) JP4717110B2 (OSRAM)
KR (1) KR101324920B1 (OSRAM)
AR (1) AR054015A1 (OSRAM)
AT (1) ATE539742T1 (OSRAM)
CA (1) CA2599252C (OSRAM)
CY (1) CY1112794T1 (OSRAM)
DK (1) DK1858504T3 (OSRAM)
ES (1) ES2380168T3 (OSRAM)
HR (1) HRP20120177T1 (OSRAM)
ME (1) ME02948B (OSRAM)
MX (1) MX2007010814A (OSRAM)
PL (1) PL1858504T3 (OSRAM)
PT (1) PT1858504E (OSRAM)
RS (1) RS52237B (OSRAM)
SI (1) SI1858504T1 (OSRAM)
TW (1) TWI388318B (OSRAM)
WO (1) WO2006094900A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
US20190183927A1 (en) * 2016-08-11 2019-06-20 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
WO1999007419A1 (en) 1997-08-07 1999-02-18 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
AU1073400A (en) 1999-10-11 2001-04-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
JP4361493B2 (ja) 2002-12-10 2009-11-11 ガンブロ・ルンディア・エービー 腹膜透析用薬剤の製造のための医学的溶液を調製する方法
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
EP1858504B1 (en) 2012-01-04
JP4717110B2 (ja) 2011-07-06
MX2007010814A (es) 2007-11-07
US20080138443A1 (en) 2008-06-12
PT1858504E (pt) 2012-04-10
ME02948B (me) 2012-10-31
AR054015A1 (es) 2007-05-30
CA2599252C (en) 2013-07-30
JP2008532601A (ja) 2008-08-21
TW200714279A (en) 2007-04-16
RS52237B (sr) 2012-10-31
SI1858504T1 (sl) 2012-04-30
DK1858504T3 (da) 2012-04-30
ES2380168T3 (es) 2012-05-09
PL1858504T3 (pl) 2012-05-31
JP2010207630A (ja) 2010-09-24
EP1858504A1 (en) 2007-11-28
KR20070116630A (ko) 2007-12-10
HRP20120177T1 (hr) 2012-03-31
KR101324920B1 (ko) 2013-11-01
JP5366894B2 (ja) 2013-12-11
WO2006094900A1 (en) 2006-09-14
CY1112794T1 (el) 2016-02-10
CA2599252A1 (en) 2006-09-14
ATE539742T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
TW287108B (OSRAM)
Topley et al. In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.
US6214802B1 (en) Peritoneal dialysis fluid
EA025137B1 (ru) Раствор для диализа, включающий одно или более соединений креатина и способ его получения
JPS63146824A (ja) 血液保存及び賦活用薬剤
EA013846B1 (ru) Фармацевтическая композиция, содержащая лактат, и ее применение
US20090232908A1 (en) Stable aqueous solution containing sodium pyruvate, and the preparation and use thereof
US20110256522A1 (en) Arginine-containing compositions and methods for treating red blood cells
CA2788865A1 (en) Composition comprising as active ingredient l-carnitine in combination with hydroxykynurenine-0-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
CN104382891B (zh) 通过施用肌酸化合物的透析患者中的细胞保护
EP0270026A2 (en) Pharmaceutical preparation comprising vitamin B6
JP5366894B2 (ja) 生体適合性が改善されたカルニチンを含有する腹膜透析液
EP0562188B1 (en) Composition for tissues to sustain viability and biological functions in surgery and storage
JP3182564B2 (ja) 栄養組成物
CA1334575C (en) Substitution fluid preparation comprising 3-hydroxybutyric acid (beta-hydroxybutyric acid) and its salts
RU2226093C1 (ru) Кардиоплегический раствор "инфузол"
US20030013767A1 (en) Method of treating weight loss using creatine
Bocock et al. Hepatic sulfur amino acid metabolism in rats with chronic renal failure
JPS58500526A (ja) 非経口栄養供給のための改良溶液
Chen et al. THE EFFICACY OF NON-LACTATE-GENERATING METABOLITES AS SUBSTRATES FOR MAINTAINING DONOR TISSUES1
JPH0733601A (ja) 組織保存用組成物
US20080095865A1 (en) Composition and method for increasing lean muscle mass, decreasing muscle loss, increasing muscle strength and improving athletic performance
Sutton Causes and prevention of calcium-containing renal calculi
AU653586B2 (en) Composition for tissues to sustain viability and biological functions in surgery and storage
US20240042115A1 (en) Peritoneal dialysis solution

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees